Published in J Virol on February 01, 2005
Viral AlkB proteins repair RNA damage by oxidative demethylation. Nucleic Acids Res (2008) 1.19
An examination of the electrostatic interactions between the N-terminal tail of the Brome Mosaic Virus coat protein and encapsidated RNAs. J Mol Biol (2012) 1.04
Interaction between Brome mosaic virus proteins and RNAs: effects on RNA replication, protein expression, and RNA stability. J Virol (2005) 1.04
Role of RNase MRP in viral RNA degradation and RNA recombination. J Virol (2010) 0.91
The combined effect of environmental and host factors on the emergence of viral RNA recombinants. PLoS Pathog (2010) 0.88
Selective repression of translation by the brome mosaic virus 1a RNA replication protein. J Virol (2006) 0.81
The proteasomal Rpn11 metalloprotease suppresses tombusvirus RNA recombination and promotes viral replication via facilitating assembly of the viral replicase complex. J Virol (2014) 0.79
Insights into the single-cell reproduction cycle of members of the family Bromoviridae: lessons from the use of protoplast systems. J Virol (2008) 0.76
A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res (1988) 26.70
Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol (1999) 4.37
Comparison of the replication of positive-stranded RNA viruses of plants and animals. Adv Virus Res (1996) 4.02
A mechanism for initiating RNA-dependent RNA polymerization. Nature (2001) 3.99
Protein-priming of DNA replication. Annu Rev Biochem (1991) 3.49
A positive-strand RNA virus replication complex parallels form and function of retrovirus capsids. Mol Cell (2002) 3.41
Host factors in positive-strand RNA virus genome replication. J Virol (2003) 3.28
Cellular factors in the transcription and replication of viral RNA genomes: a parallel to DNA-dependent RNA transcription. Virology (1998) 2.98
Genetic recombination between RNA components of a multipartite plant virus. Nature (1986) 2.76
Polynucleotide phosphorylase functions both as a 3' right-arrow 5' exonuclease and a poly(A) polymerase in Escherichia coli. Proc Natl Acad Sci U S A (2000) 2.32
A brome mosaic virus intergenic RNA3 replication signal functions with viral replication protein 1a to dramatically stabilize RNA in vivo. J Virol (1999) 2.31
Cytoplasmic polyadenylation in development and beyond. Microbiol Mol Biol Rev (1999) 2.29
Different mechanisms of recognition of bacteriophage Q beta plus and minus strand RNAs by Q beta replicase. J Mol Biol (1993) 2.22
Brome mosaic virus polymerase-like protein 2a is directed to the endoplasmic reticulum by helicase-like viral protein 1a. J Virol (2000) 2.13
Telomeric function of the tRNA-like structure of brome mosaic virus RNA. Proc Natl Acad Sci U S A (1989) 2.12
The 5' ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J Virol (1995) 2.10
FUNCTIONS OF THE 3'-UNTRANSLATED REGIONS OF POSITIVE STRAND RNA VIRAL GENOMES. Annu Rev Phytopathol (1999) 1.99
High efficiency T7 polymerase synthesis of infectious RNA from cloned brome mosaic virus cdna and effects of 5' extensions on transcript infectivity. Virology (1987) 1.97
Replication in vivo of mutant brome mosaic virus RNAs defective in aminoacylation. J Mol Biol (1989) 1.97
Analysis of the role of brome mosaic virus 1a protein domains in RNA replication, using linker insertion mutagenesis. J Virol (1990) 1.97
Mutational analysis of cis-acting sequences and gene function in RNA3 of cucumber mosaic virus. Virology (1993) 1.77
Brome mosaic virus Protein 1a recruits viral RNA2 to RNA replication through a 5' proximal RNA2 signal. J Virol (2001) 1.74
Initiation of (-)-strand RNA synthesis catalyzed by the BMV RNA-dependent RNA polymerase: synthesis of oligonucleotides. Virology (1996) 1.74
A replication silencer element in a plus-strand RNA virus. EMBO J (2003) 1.72
CCA addition by tRNA nucleotidyltransferase: polymerization without translocation? EMBO J (1998) 1.71
Initiation of minus-strand RNA synthesis by the brome mosaicvirus RNA-dependent RNA polymerase: use of oligoribonucleotide primers. J Virol (1996) 1.70
Purification and characterization of Escherichia coli RNase T. J Biol Chem (1985) 1.68
tRNA nucleotidyltransferase is not essential for Escherichia coli viability. EMBO J (1987) 1.63
A minimal RNA promoter for minus-strand RNA synthesis by the brome mosaic virus polymerase complex. J Mol Biol (1999) 1.59
Analysis of the gene start and gene end signals of human respiratory syncytial virus: quasi-templated initiation at position 1 of the encoded mRNA. J Virol (1997) 1.57
A novel 3'-end repair mechanism in an RNA virus. Proc Natl Acad Sci U S A (1997) 1.55
Terminal nucleotidyl transferase activity of recombinant Flaviviridae RNA-dependent RNA polymerases: implication for viral RNA synthesis. J Virol (2001) 1.53
Identification of terminal adenylyl transferase activity of the poliovirus polymerase 3Dpol. J Virol (1994) 1.52
Characterization of the E.coli poly(A) polymerase: nucleotide specificity, RNA-binding affinities and RNA structure dependence. Nucleic Acids Res (2000) 1.45
This is the end: processing, editing and repair at the tRNA 3'-terminus. Biol Chem (2001) 1.44
Solution structure of the 3'-end of brome mosaic virus genomic RNAs. Conformational mimicry with canonical tRNAs. J Mol Biol (1994) 1.44
Initiation of RNA synthesis in vitro by vesicular stomatitis virus. Role of ATP. J Biol Chem (1979) 1.43
Genetic recombination in brome mosaic virus: effect of sequence and replication of RNA on accumulation of recombinants. J Virol (1992) 1.42
RNA elements required for RNA recombination function as replication enhancers in vitro and in vivo in a plus-strand RNA virus. EMBO J (1999) 1.39
Mechanistic analysis of RNA synthesis by RNA-dependent RNA polymerase from two promoters reveals similarities to DNA-dependent RNA polymerase. RNA (1998) 1.37
Recombination and polymerase error facilitate restoration of infectivity in brome mosaic virus. J Virol (1993) 1.37
Productive and abortive initiation of transcription in vitro at the lac UV5 promoter. Biochemistry (1980) 1.29
Multiple interactions within the hepatitis C virus RNA polymerase repress primer-dependent RNA synthesis. J Mol Biol (2003) 1.28
Interactions between the structural domains of the RNA replication proteins of plant-infecting RNA viruses. J Virol (1998) 1.24
Model for the mechanism of bacteriophage T7 RNAP transcription initiation and termination. J Mol Biol (1992) 1.22
TYMV RNA As a substrate of the tRNA nucleotidyltransferase. FEBS Lett (1970) 1.18
Brome mosaic virus, good for an RNA virologist's basic needs. Mol Plant Pathol (2000) 1.18
PNPase activity determines the efficiency of mRNA 3'-end processing, the degradation of tRNA and the extent of polyadenylation in chloroplasts. EMBO J (2002) 1.18
Polymerization of nontemplate bases before transcription initiation at the 3' ends of templates by an RNA-dependent RNA polymerase: an activity involved in 3' end repair of viral RNAs. Proc Natl Acad Sci U S A (2000) 1.13
Functional overlap of tRNA nucleotidyltransferase, poly(A) polymerase I, and polynucleotide phosphorylase. J Biol Chem (1997) 1.12
RNA synthesis by the brome mosaic virus RNA-dependent RNA polymerase: transition from initiation to elongation. Virology (1997) 1.11
Poliovirus RNA recombination in cell-free extracts. RNA (1997) 1.11
Repair in vivo of altered 3' terminus of cymbidium ringspot tombusvirus RNA. Virology (1993) 1.04
Amplification in vivo of brome mosaic virus RNAs bearing 3' noncoding region from cucumber mosaic virus. Virology (1994) 1.03
Template sequence near the initiation nucleotide can modulate brome mosaic virus RNA accumulation in plant protoplasts. J Virol (2004) 0.99
In vivo restoration of biologically active 3' ends of virus-associated RNAs by nonhomologous RNA recombination and replacement of a terminal motif. J Virol (1996) 0.98
Characterization of RNA products associated with or aborted by a viral RNA-dependent RNA polymerase. Virology (1997) 0.97
Unique nucleotide differences in the conserved 3' termini of brome mosaic virus RNAs are maintained through their optimization of genome replication. Virology (1992) 0.97
Brome mosaic virus defective RNAs generated during infection of barley plants. J Gen Virol (1999) 0.94
tRNA-like structure regulates translation of Brome mosaic virus RNA. J Virol (2004) 0.94
Sequences 5' of the conserved tRNA-like promoter modulate the initiation of minus-strand synthesis by the brome mosaic virus RNA-dependent RNA polymerase. Virology (1998) 0.93
Brome mosaic virus RNA syntheses in vitro and in barley protoplasts. J Virol (2003) 0.89
Replication of cymbidium ringspot virus satellite RNA mutants. Virology (1995) 0.88
Analysis of RNA stability and (-) strand content in viral infections using biotinylated RNA probes. J Virol Methods (1990) 0.87
Kinetic mechanism of tRNA nucleotidyltransferase from Escherichia coli. J Biol Chem (1977) 0.86
In vivo repair of 3'-end deletions in a TCV satellite RNA may involve two abortive synthesis and priming events. Virology (1996) 0.86
Template-independent repair of the 3' end of cucumber mosaic virus satellite RNA controlled by RNAs 1 and 2 of helper virus. J Virol (1998) 0.85
Replicase-binding sites on plus- and minus-strand brome mosaic virus RNAs and their roles in RNA replication in plant cells. J Virol (2004) 0.85
RNA-directed RNA polymerases from healthy and from virus-infected cucumber. Proc Natl Acad Sci U S A (1986) 0.84
Study of the Escherichia coli tRNA nucleotidyltransferase. Interactions of the enzyme with tRNA. Biochim Biophys Acta (1974) 0.81
Taxonomic position of sugarcane streak mosaic virus in the family Potyviridae. Arch Virol (2002) 0.80
Bipartite 3'-cis-acting signal for replication in yeast 23 S RNA virus and its repair. J Biol Chem (2004) 0.77
The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin Infect Dis (1996) 2.52
Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer (1998) 2.36
Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler Thromb Vasc Biol (2001) 2.01
Nosocomial pneumonia in patients having bone marrow transplant. Attributable mortality and risk factors. Cancer (1992) 1.47
The N-terminal half of the brome mosaic virus 1a protein has RNA capping-associated activities: specificity for GTP and S-adenosylmethionine. Virology (1999) 1.46
Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci U S A (1996) 1.44
Overcoming cellular senescence in human cancer pathogenesis. Genes Dev (1998) 1.36
Factors regulating template switch in vitro by viral RNA-dependent RNA polymerases: implications for RNA-RNA recombination. Proc Natl Acad Sci U S A (2001) 1.33
The complete optical spectrum of liquid water measured by inelastic x-ray scattering. Proc Natl Acad Sci U S A (2000) 1.19
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. Br J Cancer (2005) 1.15
Interaction between Brome mosaic virus proteins and RNAs: effects on RNA replication, protein expression, and RNA stability. J Virol (2005) 1.04
A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis. Cancer Res (2001) 1.03
Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells. J Biol Chem (2000) 1.00
A site in the T4 bacteriophage major head protein gene that can promote the inhibition of all translation in Escherichia coli. J Mol Biol (1990) 0.97
Cloning and characterization of the Escherichia coli lit gene, which blocks bacteriophage T4 late gene expression. J Bacteriol (1987) 0.92
Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model. Hum Gene Ther (1996) 0.91
Osteocalcin-directed gene therapy for prostate-cancer bone metastasis. World J Urol (2000) 0.91
Molecular characterization and interviral relationships of a flexuous filamentous virus causing mosaic disease of sugarcane (Saccharum officinarum L.) in India. Arch Virol (1999) 0.90
Death rates in 71 men with antisocial personality disorder. A comparison with general population mortality. Psychosomatics (1996) 0.89
Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer. J Urol (1998) 0.87
Structure of sesbania mosaic virus at 3 A resolution. Structure (1995) 0.87
The burden of osteoporosis in California, 1998. Osteoporos Int (2002) 0.87
Osteocalcin is incompletely spliced in non-osseous tissues. Gene (2001) 0.86
Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models. Cancer Res (1996) 0.86
Enhanced combined tumor-specific oncolysis and suicide gene therapy for prostate cancer using M6 promoter. Cancer Gene Ther (2008) 0.85
Replicase-binding sites on plus- and minus-strand brome mosaic virus RNAs and their roles in RNA replication in plant cells. J Virol (2004) 0.85
Complete nucleotide sequence of Sesbania mosaic virus: a new virus species of the genus Sobemovirus. Arch Virol (2001) 0.85
Studies on the movement of cowpea mosaic virus using the jellyfish green fluorescent protein. Virology (1998) 0.83
In vitro radiation-induced neoplastic progression of low-grade uroepithelial tumors. Radiat Res (1994) 0.83
Establishment and characterization of a SV40 T-antigen immortalized human bronchial epithelial cell line. In Vitro Cell Dev Biol (1992) 0.82
In vivo arginine production and nitric oxide synthesis in pregnant Indian women with normal and low body mass indices. Eur J Clin Nutr (2009) 0.82
Apolipoprotein E deficiency effects on learning in mice are dependent upon the background strain. Behav Brain Res (2001) 0.82
A molecular genetic model of human bladder carcinogenesis. Semin Cancer Biol (1993) 0.81
Tissue-specific promoters in gene therapy for the treatment of prostate cancer. Mol Urol (2000) 0.81
A conditionally replicative, Wnt/beta-catenin pathway-based adenovirus therapy for anaplastic thyroid cancer. Cancer Gene Ther (2007) 0.81
Reconstitution of estrogen-dependent transcriptional activation of an adenoviral target gene in select regions of the rat mammary gland. Endocrinology (1998) 0.81
Selective repression of translation by the brome mosaic virus 1a RNA replication protein. J Virol (2006) 0.81
Human prostate cancer progression models and therapeutic intervention. Hinyokika Kiyo (1997) 0.80
Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulations. Urol Oncol (2011) 0.80
Regulation of prostacyclin and prostaglandin E(2) receptor mediated responses in adult rat dorsal root ganglion cells, in vitro. Br J Pharmacol (2001) 0.80
Cytotoxic effects of recombinant adenovirus p53 and cell cycle regulator genes (p21 WAF1/CIP1 and p16CDKN4) in human prostate cancers. J Urol (1997) 0.79
Smoking cessation in Taiwanese male smokers with coronary artery disease: influencing factors and policy implications. Int Nurs Rev (2013) 0.79
Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells. Int J Cancer (2001) 0.79
In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy. Cancer Gene Ther (1999) 0.79
5' Regulatory region of ubiquitin 2 gene from Porteresia coarctata makes efficient promoters for transgene expression in monocots and dicots. Plant Cell Rep (2013) 0.78
Chromosome losses in tumorigenic revertants of EJ/ras-expressing somatic cell hybrids. Cancer Genet Cytogenet (1992) 0.78
Genomic sequence of physalis mottle virus and its evolutionary relationship with other tymoviruses. Arch Virol (1998) 0.77
Structure of Sesbania mosaic virus at 4.7 A resolution and partial sequence of the coat protein. J Mol Biol (1993) 0.77
Antitumor activity of Ad-IU2, a prostate-specific replication-competent adenovirus encoding the apoptosis inducer, TRAIL. Cancer Gene Ther (2009) 0.77
p53 adenoviral vector (Ad-CMV-p53) induced prostatic growth inhibition of primary cultures of human prostate and an experimental rat model. J Gene Med (2001) 0.76
Serum-free recombinant production of adenovirus using a hollow fiber capillary system. Biotechniques (2001) 0.76
Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model. Cancer Gene Ther (1998) 0.76
Continuous exposure of Suffolk ewes to an equatorial photoperiod disrupts expression of the annual breeding season. Biol Reprod (1990) 0.75
Blockage while giving intramuscular and subcutaneous injections. J Indian Med Assoc (2004) 0.75
Steroids in tuberculous meningitis. J Assoc Physicians India (1995) 0.75
[Effect of intraaortic balloon pumping on ventricular arrhythmias (author's transl)]. Kyobu Geka (1980) 0.75
Historical significance of contraception. Bull Indian Inst Hist Med Hyderabad (1985) 0.75
Arrhythmia and atrial secundum defect. Analysis of predisposing and precipitating factors responsible for arrhythmias in relation to the age of the patients. Nihon Geka Hokan (1978) 0.75
Oesophageal spasm and cardiac pain. J Assoc Physicians India (1987) 0.75
Circulatory effects of dobutamine and dopamine in dogs following experimental injury of the sino-atrial node. Nihon Geka Hokan (1979) 0.75
Problem in injecting penicillin. J Indian Med Assoc (2000) 0.75
Assembly of physalis mottle virus capsid protein in Escherichia coli and the role of amino and carboxy termini in the formation of the icosahedral particles. J Mol Biol (1997) 0.75
Why spinal CSF pressure rises in space occupying lesions (SOL) of brain. J Indian Med Assoc (2002) 0.75
Validity of an arterial system model: a quantitative evaluation. IEEE Trans Biomed Eng (1980) 0.75
Cause of dietary deficiency of calcium. J Indian Med Assoc (2002) 0.75
18F-2-fluoro-2-deoxy-D-glucose positron emission tomography of head and neck in patients with nasopharyngeal carcinomas. Oncol Rep (2011) 0.75
An algorithm for calculation of background activity in thallium-201 myocardial imaging. J Nucl Med (1981) 0.75
Structure of Sesbania mosaic virus at 3 A resolution. Biophys Chem (1997) 0.75
Influence of vascular parameters on the effectiveness of intra-aortic balloon pumping: a model study. Med Biol Eng Comput (1982) 0.75
Tissue polypeptide specific antigen for early prediction of non-small cell lung cancer recurrence. Oncol Rep (2011) 0.75